Hearing that cancer has spread can be frightening for a patient and their family. But metastatic cancer does not mean that treatment options have ended. Today, doctors have several ways to treat cancer that has spread, including chemotherapy, targeted therapy, immunotherapy, hormone therapy, radiation, surgery in selected cases, and newer treatments being studied in clinical trials.
Metastatic cancer means that cancer has moved from the place where it first started to another part of the body. The new tumor is still named after the original cancer. For example, if breast cancer spreads to the lungs, it is called metastatic breast cancer, not lung cancer.
Many people also wonder whether metastatic cancer always means Stage 4. For many solid cancers, distant spread is classified as Stage 4. However, the exact staging system can differ between cancer types, so the words “metastatic” and “Stage 4” are not always interchangeable in every situation.
Treatment today is also more personalized than simply giving the same medicine to everyone with advanced cancer. Doctors may look at the type of cancer, where it has spread, previous treatments, biopsy results, genetic or biomarker test results, and the patient’s overall health before choosing a treatment plan.
The goal may be to shrink the cancer, slow its growth, control it for a longer period, reduce symptoms, or improve quality of life. In some cancers, long-term control is possible, while selected metastatic cancers can still respond very well to treatment.
What Is Metastatic Cancer?
Cancer starts when abnormal cells grow in a part of the body. Sometimes these cells stay near the original tumor. In other cases, they can enter the blood or lymph system and travel to another part of the body. If they settle there and form a new tumor, this is called metastasis.
Primary Cancer vs Metastatic Cancer
The primary cancer is where the cancer first began. A metastatic tumor is cancer that has spread from that original site.
For example:
- Breast cancer that spreads to the bones is metastatic breast cancer.
- Colon cancer that spreads to the liver is metastatic colon cancer.
- Lung cancer that spreads to the brain remains lung cancer, even though the brain is now affected.
This difference matters because doctors choose treatment based mainly on the original cancer type and its biology, not simply on the organ where the metastatic tumor is found.
Where Can Cancer Spread?
Metastatic cancer can reach different parts of the body. The most common distant sites include:
- Liver
- Lungs
- Bones
- Brain
- Other organs or tissues
The pattern of spread is different for each type of cancer. For example, some cancers commonly spread to the liver, while others are more likely to involve the bones or lungs.
A person may have cancer in one distant organ or in several areas at the same time. The number, size, and location of these tumors can affect treatment planning.
Why Is Metastatic Cancer Often Called Stage 4?
For many solid cancers, cancer that has spread to a distant part of the body is classified as Stage 4. In the TNM system, distant metastasis is represented by M1.
But staging is not exactly the same for every cancer. Some cancers use different staging systems, and the meaning of Stage 4 can vary by cancer type.
That is why a doctor will look beyond the stage number. The original cancer, where it has spread, biopsy findings, biomarkers, previous treatment, and the patient’s health all help shape the treatment plan.
What Are the Latest Treatments for Metastatic Cancer?
When cancer has spread to another part of the body, treatment is usually planned around the type of cancer, where it has spread, previous treatment, and the patient’s overall health. Doctors may use one treatment or combine several approaches.
There is no single treatment that works for every metastatic cancer. A treatment that is useful for metastatic breast cancer, for example, may be very different from the treatment used for metastatic colon, lung, prostate, or kidney cancer.
Here is a simple overview of the main treatment options used today:
| Treatment |
What it may do |
| Immunotherapy |
Helps the immune system recognize and attack cancer cells |
| Targeted therapy |
Targets specific changes or proteins that help cancer grow |
| Chemotherapy |
Kills or slows fast-growing cancer cells |
| Hormone therapy |
Slows cancers that depend on hormones to grow |
| Radiation therapy |
Controls a tumor in a specific area and can help relieve symptoms |
| Surgery |
Removes selected tumors when surgery is appropriate |
| Radiopharmaceuticals |
Uses radioactive medicine to reach certain cancer cells or tissues |
| Combination therapy |
Uses two or more treatments together |
| Clinical trials |
Gives eligible patients access to treatments or treatment combinations being studied |
Some people may receive treatment for the cancer itself along with supportive or palliative care to manage pain, nutrition problems, breathing difficulties, fatigue, or other symptoms.
NCI explains that metastatic cancer treatment can involve systemic treatments such as chemotherapy, hormone therapy, targeted therapy, or immunotherapy, along with local treatments such as surgery or radiation in selected situations. The choice is guided by the original cancer, where it has spread, previous treatment, and the person’s health.
Immunotherapy for Metastatic Cancer
Immunotherapy has changed the way some advanced cancers are treated. Instead of directly attacking cancer cells like traditional chemotherapy, some immunotherapy medicines help the body’s own immune system recognize and attack them.
One of the main types is called immune checkpoint inhibitor therapy.
How Does Immunotherapy Work?
Our immune system has natural “brakes” that stop immune cells from attacking healthy tissues too strongly. Some cancer cells can use these brakes to avoid being attacked.
Checkpoint inhibitors block certain signals that act like these brakes. This can allow T cells, a type of immune cell, to respond more strongly against cancer.
Three important checkpoint proteins you may hear about are:
Different medicines target different checkpoints. For example, some drugs block PD-1, some block PD-L1, and others target CTLA-4. In certain cancers, two immunotherapy medicines may also be used together.
Which Metastatic Cancers Can Be Treated With Immunotherapy?
Immunotherapy is used for some patients with several types of advanced or metastatic cancer. It is not limited to one cancer type.
Depending on the cancer, checkpoint inhibitors may be considered for cancers such as:
- Lung cancer
- Melanoma
- Kidney cancer
- Bladder and other urinary tract cancers
- Head and neck cancers
- Some breast cancers
- Some colorectal cancers
- Liver cancer
- Other cancers in selected situations
The exact drug and whether it is suitable can vary even among patients who have the same type of cancer.
What Is the Role of Biomarker Testing?
Before choosing immunotherapy in some cancers, doctors may recommend biomarker testing.
The test looks for certain features in the cancer that may help predict whether a treatment could work. Depending on the cancer, testing may look at markers such as PD-L1, MSI/MMR, or tumor mutational burden, along with other molecular changes.
A biomarker result does not guarantee that immunotherapy will work. It is one piece of information doctors use along with the cancer type, stage, previous treatment, symptoms, and overall health.
What Are the Side Effects of Immunotherapy?
Immunotherapy works by changing the activity of the immune system. Because of this, the immune system can sometimes affect healthy organs as well.
Some patients may develop:
- Skin rash or itching
- Tiredness
- Fever or flu-like symptoms
- Diarrhea
- Joint or muscle pain
- Thyroid or other hormone problems
- Inflammation of the lungs, liver, bowel, or other organs
Most side effects are manageable when recognized early, but some immune-related reactions can be serious. They can also appear during treatment or, in some cases, after treatment.
Patients receiving immunotherapy should tell their cancer team about new or unusual symptoms rather than waiting for the next appointment.
Why Isn’t Immunotherapy Right for Every Metastatic Cancer Patient?
Immunotherapy is a major treatment option, but it is not a universal treatment for metastatic cancer.
Some cancers do not respond well to currently available immunotherapy. In other cases, the tumor may not have biomarkers that support its use, or another treatment may be more appropriate based on the patient’s cancer and previous treatment.
Doctors also consider the patient’s general health and the possible risks of treatment. The final choice may be immunotherapy alone, immunotherapy with another treatment, or a completely different approach.
That is why a metastatic cancer treatment plan should be built around the individual cancer and the patient’s medical reports, rather than choosing a treatment simply because it is considered a newer option.
Targeted Therapy for Metastatic Cancer
Targeted therapy is a type of cancer treatment designed to act on specific proteins or molecular changes that help cancer cells grow, divide, or spread. Unlike traditional chemotherapy, which mainly attacks fast-growing cells, targeted medicines are designed around particular features of the cancer. This is one of the main ideas behind precision medicine.
What Makes Targeted Therapy Different?
Cancer cells can carry changes in their genes or proteins that help them keep growing. Some of these changes can be used as treatment targets.
You may hear names such as:
- HER2
- EGFR
- ALK
- BRAF
- KRAS
- ROS1
These are examples, not a checklist for every cancer patient. A particular target may be relevant to one cancer but not another. Even two people with the same type of cancer can have different molecular changes.
Why Is Molecular or Genomic Testing Important?
Before using some targeted medicines, doctors may test the tumor for specific biomarkers. This can involve a biopsy sample, tumor tissue already collected during an earlier procedure, or, in selected situations, a blood-based liquid biopsy.
The test may look for gene changes, proteins, or other features of the cancer. The results can show whether a targeted treatment may be an option.
For advanced or metastatic cancer, genomic or biomarker testing is often considered because the information can help doctors look for treatments that match the biology of the tumor.
But a matching biomarker does not guarantee that a treatment will work. Cancer is complex, and other features of the tumor can affect the response.
How Does Precision Medicine Work?
Precision medicine means choosing treatment using information about the individual cancer rather than relying only on the cancer’s location or stage.
For example, two people may both have metastatic lung cancer, but their tumors may have different molecular changes. One may have a target that can be treated with a specific targeted drug, while the other may need a different approach.
That is why the same treatment plan is not suitable for every patient with metastatic cancer.
When Can Targeted Therapy Be Useful?
Targeted therapy may be considered when testing shows a specific target for which an appropriate treatment is available.
It can be used alone in some situations or combined with other treatments such as chemotherapy, hormone therapy, immunotherapy, or radiation. The choice depends on the cancer type, biomarker results, previous treatment, and the patient’s overall condition.
What Happens If Cancer Becomes Resistant to Targeted Therapy?
Targeted therapy may work well for a period of time and then stop controlling the cancer. This is called treatment resistance.
Cancer cells can change while treatment is being given. Some cells may develop a new change in the original target, while others may find another way to continue growing.
If the cancer starts growing again, the doctor may repeat scans and, in selected cases, recommend another biopsy or biomarker test. The next treatment could be a different targeted medicine, another type of cancer treatment, or a clinical trial.
Chemotherapy for Metastatic Cancer
Chemotherapy is still an important treatment for many metastatic cancers. It uses medicines that kill cancer cells or slow their growth. Because the medicines travel through the bloodstream, they can reach cancer cells in different parts of the body.
For some patients, chemotherapy may be the main treatment. For others, it may be combined with another treatment or used after a previous treatment stops working.
When Is Chemotherapy Used?
The role of chemotherapy depends heavily on the type of cancer.
It may be used to:
- Shrink metastatic tumors
- Slow cancer growth
- Control cancer that has spread
- Reduce symptoms caused by a tumor
- Help another treatment work better
- Treat cancer that has returned after earlier treatment
Chemotherapy can also be given before or after surgery or radiation in certain cancers.
Combination Chemotherapy
Sometimes doctors use two or more chemotherapy medicines together. Different drugs attack cancer cells in different ways, which may make the combination more effective for certain cancers.
The exact combination is chosen according to the cancer type, previous treatment, overall health, and the goal of treatment.
Chemotherapy With Immunotherapy
In some cancers, chemotherapy is combined with immunotherapy. Chemotherapy may reduce or control the cancer while immunotherapy helps the immune system recognize and attack cancer cells.
This combination is not suitable for every metastatic cancer. The cancer type and other medical factors guide the decision.
Chemotherapy With Targeted Therapy
Targeted therapy may also be combined with chemotherapy when there is a suitable reason to use both. This can happen when the cancer has a target that can be treated with a specific medicine.
The combination, timing, and number of treatment cycles vary from one cancer to another.
Common Side Effects of Chemotherapy
Because chemotherapy can also affect some healthy cells that grow quickly, side effects may occur. Common problems include:
- Tiredness
- Nausea or vomiting
- Mouth sores
- Hair loss
- Appetite changes
- Changes in blood counts
- Higher risk of infection
- Diarrhea or constipation
Not everyone experiences the same side effects. The medicines used, dose, treatment schedule, and the person’s health all play a role.
How Do Doctors Know If Chemotherapy Is Working?
Doctors usually use a combination of physical examination, symptoms, blood tests, and imaging scans to follow the cancer.
Depending on the cancer, CT, MRI, PET scans, tumor markers, or other tests may be used. A smaller tumor is one possible sign of response, but doctors also look at whether the cancer has stopped growing or whether new tumors have appeared.
Hormone Therapy for Metastatic Cancer
Some cancers use hormones as a signal to grow. Hormone therapy, also called endocrine therapy, works by reducing the body’s production of certain hormones or by stopping those hormones from acting on cancer cells. It is mainly used for cancers such as some breast and prostate cancers.
Hormone Receptor-Positive Cancers
In breast cancer, doctors may test the tumor for hormone receptors such as estrogen or progesterone receptors. If the cancer depends on these hormones, hormone therapy may become part of the treatment plan.
Prostate cancer is another major example. Treatment may reduce the effect or production of male hormones that can help prostate cancer grow.
Hormone Therapy Alone or With Other Treatment
Hormone therapy can sometimes be used on its own, but it is also commonly combined with other cancer treatments.
For example, depending on the cancer and its biomarkers, doctors may combine hormone therapy with a targeted medicine or another systemic treatment. The aim is to control the cancer while limiting unnecessary treatment.
What If Hormone Therapy Stops Working?
Cancer can sometimes become resistant to hormone treatment. If tests show that the cancer is growing despite treatment, the oncology team may consider another hormone-based treatment, add a different medicine, or move to another type of therapy.
For prostate cancer, regular PSA testing is commonly used to help monitor response. For breast cancer, doctors may use examinations, imaging, and other tests depending on the situation.
Radiation Therapy for Metastatic Cancer
Radiation therapy uses high-energy radiation to damage the DNA of cancer cells, which can stop them from dividing and cause them to die. In metastatic cancer, radiation is often used to treat a particular area rather than the whole body.
It can be useful when a metastatic tumor is causing pain, pressure, bleeding, or another local problem. In selected patients, radiation may also be used to control a limited number of metastatic tumors.
Radiation for the Primary Tumor
Even when cancer has spread, radiation may sometimes be used on the original tumor. This can help control the tumor or relieve problems caused by its location.
Whether this is useful depends on the cancer type, symptoms, previous treatment, and the overall treatment plan.
Radiation for Bone Metastases
Bone metastases can cause pain and, in some cases, increase the risk of fractures or pressure on the spinal cord.
Radiation can be used to treat painful bone metastases and help reduce symptoms. The treatment schedule may involve a single session or several sessions, depending on the situation.
Radiation for Brain Metastases
When cancer spreads to the brain, treatment may include radiation therapy, stereotactic radiosurgery, surgery, systemic treatment, or a combination, depending on the number, size, location, and type of tumors.
Stereotactic radiosurgery is a focused form of radiation that can deliver a high dose to selected brain tumors while limiting exposure to nearby tissue.
External Beam Radiation
With external beam radiation, a machine outside the body directs radiation toward the tumor. It is a local treatment, so the radiation is aimed at a specific area rather than being given throughout the body.
Doctors choose the dose and schedule based on the tumor’s location, size, nearby healthy tissues, symptoms, and the overall treatment goal.
Palliative Radiation
Radiation can also be given as palliative treatment. Here, the goal is to reduce symptoms rather than remove every cancer cell.
For example, radiation may help with:
- Bone pain
- Pressure from a tumor
- Bleeding from a tumor
- Symptoms caused by a brain metastasis
- Other problems caused by a specific metastatic tumor
Palliative radiation can be used alongside systemic cancer treatment when appropriate. It is focused on helping the patient feel better and maintain quality of life.
Surgery for Metastatic Cancer
A diagnosis of metastatic cancer does not automatically mean that surgery is off the table. In some patients, surgery can still have a role. The decision depends on where the cancer has spread, how many metastatic tumors are present, whether they can be removed safely, and how the cancer is responding to other treatment.
For example, if cancer has spread to only a small number of areas, doctors may sometimes consider removing those tumors or treating them with another local treatment. This is sometimes described as oligometastatic disease, meaning there are only a limited number of metastatic sites. Research is still ongoing to understand which patients benefit most from directly treating these metastases.
When Can Surgery Be Considered?
Surgery may be discussed when:
- There are only a few metastatic tumors
- The metastatic tumors can be removed safely
- The primary tumor is causing a serious local problem
- Removing a tumor may help control the disease in a selected situation
- Surgery is part of a larger treatment plan
The situation can be quite different from one cancer to another.
Surgery for Liver Metastases
Some patients with metastatic colorectal cancer, for example, may have cancer that has spread to the liver but remains limited enough for surgery or another local treatment to be considered.
Doctors look at the number and location of liver tumors, how much healthy liver would remain after surgery, whether cancer is present elsewhere, and the patient’s overall health.
Surgery for Lung Metastases
In selected patients, surgery may be considered when there are a limited number of tumors in the lungs and the primary cancer is otherwise controlled.
It is not appropriate for every patient with lung metastases. Imaging and the full treatment history are needed before making that decision.
Surgery for Brain Metastases
Brain metastases can sometimes be treated with surgery, particularly when there is a tumor that can be safely removed and is causing pressure or other symptoms. Radiation therapy, including stereotactic approaches, may also be considered depending on the number, size, and location of the brain tumors.
Surgery to Relieve Symptoms
Sometimes surgery is not aimed at removing all of the cancer.
It may instead be used to deal with a problem caused by the tumor, such as blockage, bleeding, pressure, or another serious complication. In these situations, the goal is to make the patient more comfortable or improve an important body function.
Surgery Along With Systemic Treatment
Surgery is often only one part of the plan. A patient may receive chemotherapy, targeted therapy, immunotherapy, or hormone therapy before or after surgery, depending on the cancer.
This combined approach can be useful when doctors need to treat both the visible tumors and cancer cells elsewhere in the body.
Radiopharmaceuticals and Targeted Radionuclide Therapy
Radiopharmaceuticals are medicines that contain a radioactive substance. Some are designed to travel to particular tissues or attach to specific molecules found on cancer cells. Once they reach the target, the radiation can damage nearby cancer cells.
This is different from ordinary external radiation, where a machine outside the body directs radiation toward a tumor.
How Does Targeted Radionuclide Therapy Work?
A targeted radionuclide treatment generally has two important parts:
- A targeting molecule that can recognize or attach to a particular feature of the cancer cell
- A radioactive component that delivers radiation after reaching the target
One example is lutetium Lu-177 dotatate, which targets somatostatin receptors found on certain neuroendocrine tumor cells. It is approved for somatostatin-receptor-positive gastroenteropancreatic neuroendocrine tumors.
Another example is Lu-177 PSMA-directed therapy, which targets PSMA on certain prostate cancer cells and is used in selected metastatic prostate cancer settings.
What About Bone Metastases?
Some radiopharmaceuticals are designed to reach areas of increased bone activity. Radium-223, for example, is used in certain prostate cancer situations involving bone metastases. It works differently from PSMA-targeted treatments and should not be grouped with every other radionuclide therapy.
Treatment Selection Matters
Targeted radionuclide therapy is not suitable for every person with metastatic cancer. Doctors may need specific imaging or other tests to confirm that the cancer has the target needed for the treatment.
The cancer type, previous treatments, organ function, extent of disease, and overall health are also considered.
Precision Medicine for Metastatic Cancer
Two people can have the same type of metastatic cancer and still receive completely different treatments.
Why? Their tumors may have different genes, proteins, or other molecular features.
This is where precision medicine comes in. Instead of looking only at where the cancer started, doctors can also study the biology of the tumor and look for features that may help guide treatment.
What Is Tumor Profiling?
Tumor profiling means examining cancer cells for changes that may affect how the cancer behaves or responds to treatment.
Depending on the cancer, testing may look for:
- PD-L1
- MSI or MMR changes
- HER2
- EGFR
- ALK
- ROS1
- BRAF
- KRAS
- Other cancer-specific gene or protein changes
These are examples only. Not every test is needed for every cancer.
What Is Genomic Testing?
Genomic testing looks for changes in the DNA of cancer cells. It can sometimes identify a change for which a targeted treatment is available.
NCI notes that doctors often consider genomic biomarker testing when cancer has spread or returned after treatment. The results may help identify treatments that are more likely to help and, in some situations, clinical trials for which the patient may qualify.
Tissue Biopsy vs Liquid Biopsy
A tissue biopsy uses a sample taken from the tumor. This sample can be examined under a microscope and may also be used for molecular testing.
A liquid biopsy uses a blood sample to look for cancer-related material, such as tumor DNA circulating in the blood.
Liquid biopsy can be useful in selected situations, but it does not replace tissue biopsy in every patient. The choice depends on the cancer, the test being considered, and whether enough tumor tissue is available.
Why Can Two Patients Get Different Treatments?
Imagine two patients with metastatic lung cancer. Both may have the same cancer type and similar scans, but one tumor may have an EGFR change while the other does not.
That difference can completely change the treatment discussion.
The same idea applies to other cancers. Biomarker testing is one reason modern cancer treatment is becoming more individualized rather than following one fixed plan for everyone.
Combination Treatments for Metastatic Cancer
Metastatic cancer is sometimes treated with more than one type of treatment. The reason is simple: different treatments work in different ways.
For example, one medicine may attack cancer cells directly, while another may affect the immune system or block a specific signal that helps the cancer grow.
Depending on the cancer, combinations may include:
- Chemotherapy + immunotherapy
- Targeted therapy + immunotherapy
- Hormone therapy + targeted therapy
- Radiation + systemic treatment
- Surgery + systemic treatment
These combinations are not interchangeable. A treatment combination that is useful for one cancer may have little role in another.
Doctors consider the cancer type, biomarkers, location and amount of spread, previous treatment, side effects, and the patient’s general health before choosing a combination.
Sometimes treatment is given one after another rather than at exactly the same time. For example, a patient may receive systemic treatment first and then have surgery or focused radiation for a particular tumor.
The goal is to get useful cancer control while avoiding unnecessary treatment and side effects.
Treatment for Metastatic Cancer Based on Where It Has Spread
The location of metastatic cancer can affect both symptoms and treatment choices. A tumor in the liver may need a different approach from one in the brain or bones.
Metastatic Cancer in the Liver
The liver is a common site of spread for several cancers, including colorectal and some other gastrointestinal cancers.
Treatment may include systemic therapy such as chemotherapy, targeted therapy, immunotherapy, or hormone therapy, depending on the original cancer. In selected patients with limited liver metastases, doctors may also consider surgery, ablation, or other liver-directed treatments.
The number and location of liver tumors are important when deciding whether a local treatment is possible.
Metastatic Cancer in the Lungs
Lung metastases may be treated with systemic cancer treatment because cancer cells may be present in other parts of the body as well.
However, when there are only a small number of lung metastases, local treatments such as surgery or focused radiation may sometimes be considered.
The original cancer remains an important part of the decision. Breast cancer that has spread to the lungs, for example, is treated as metastatic breast cancer rather than primary lung cancer.
Metastatic Cancer in the Bones
Bone metastases can cause pain and may weaken the affected bone. In some cases, they can also put pressure on the spinal cord or increase the risk of fracture.
Treatment may include systemic cancer therapy, radiation for painful areas, medicines that help protect bone health, and surgery when a fracture or other serious problem needs to be addressed.
The treatment plan depends on the cancer that has spread to the bone as well as the condition of the bone itself.
Metastatic Cancer in the Brain
Brain metastases require careful treatment planning because the brain is a sensitive organ.
Depending on the number, size, and location of the tumors, treatment may include surgery, stereotactic radiation, whole-brain radiation in selected situations, or systemic treatment that can work against the particular cancer.
Doctors also consider symptoms such as headaches, seizures, weakness, vision changes, or problems with balance when planning treatment.
Can Metastatic Cancer Be Cured?
The answer is different for different cancers.
Metastatic cancer is often difficult to cure because cancer cells have already moved away from the original tumor. However, some patients with metastatic cancer can still receive treatment with a long-term control or curative goal, particularly in selected situations where the spread is limited or the cancer responds very well to treatment.
For many other patients, the aim is to keep the cancer under control for as long as possible.
Cancer type makes a major difference. The behavior of metastatic testicular cancer, for example, is not the same as metastatic pancreatic cancer. The biology of the tumor, the number and location of metastases, available treatments, and response to treatment all matter.
So a Stage 4 diagnosis by itself cannot tell us exactly what will happen to an individual patient.
Can Metastatic Cancer Be Controlled for Years?
Yes, some metastatic cancers can be controlled for years with treatment. This does not happen in every cancer, and the length of control can vary greatly.
When doctors say that cancer is “controlled,” they may mean that:
- The tumors have become smaller
- The cancer has stopped growing for a period of time
- No new tumors are appearing
- Symptoms have improved
- The disease is responding well enough for the current treatment to continue
A scan may show stable disease, meaning the cancer has not grown enough to be considered progression and has not necessarily shrunk substantially.
In another patient, the tumors may shrink significantly after treatment. Some patients may have a long period before the cancer begins growing again.
What Happens If the Cancer Starts Growing Again?
Cancer can sometimes develop resistance to treatment. When that happens, doctors may repeat imaging, review the treatment history, and sometimes perform additional molecular or biomarker testing.
The next step could be a different medicine, a different combination, local treatment for a particular tumor, or a clinical trial.
NCI notes that some people live for years with metastatic cancer that is well controlled, but this varies widely according to the cancer type and the individual situation.
How Doctors Choose the Right Treatment for Metastatic Cancer
There is no single treatment plan for metastatic cancer. Even two people with the same type of cancer may receive different treatments.
The doctor first looks at where the cancer started and where it has spread. Then other details help narrow down the options.
Some of the main factors include:
- Primary cancer type: Breast, lung, colon, prostate, pancreatic, and other cancers behave differently and have different treatment options.
- Where the cancer has spread: The liver, lungs, bones, brain, and other organs may require different approaches.
- Number and size of metastatic tumors: A few small tumors may sometimes be treated with a local approach such as surgery or focused radiation.
- Previous treatment: Doctors need to know which medicines, surgery, radiation, or other treatments have already been given.
- Biopsy and pathology: The tissue report confirms the cancer type and can provide information about how the tumor looks and behaves.
- Biomarkers: Tests may look for proteins or molecular changes that can help identify a suitable targeted treatment or immunotherapy.
- Genetic or genomic testing: In some advanced cancers, testing can look for changes in the tumor that may open the door to a targeted medicine or clinical trial.
- Age and overall health: A person’s ability to tolerate treatment is part of the decision.
- Organ function: Kidney, liver, heart, lung, and other organ functions may affect which medicines can be used safely.
- Symptoms: Pain, breathing problems, bleeding, swallowing difficulties, or other symptoms may need treatment alongside the cancer itself.
- Patient’s goals: Some people may want treatment focused on shrinking the cancer, while others may place greater importance on controlling symptoms and maintaining daily life.
Doctors may also discuss more than one option. The final plan is usually based on the full picture rather than one scan result or one laboratory test.
What Happens If the First Treatment Stops Working?
Cancer treatment does not always keep working forever. Sometimes the cancer starts growing again even after it initially responded. This is called treatment resistance.
Cancer cells can change over time. Some cells may become less sensitive to a medicine, while other cells may already have features that allow them to survive treatment.
When this happens, doctors usually reassess the situation rather than simply continuing the same treatment.
Repeat Scans and Testing
CT, MRI, PET scans, blood tests, and other examinations may be used to find out whether the cancer has grown or appeared in a new area.
The doctor may also review symptoms and how well the patient is tolerating the current treatment.
Is a New Biopsy Needed?
Sometimes a repeat biopsy can provide useful information, especially when the cancer’s behavior has changed or a new treatment depends on knowing its current molecular features.
A new biopsy is not necessary for everyone. In some situations, a blood-based liquid biopsy may also be considered.
New Biomarker Testing
Cancer biomarkers can change over time. A test performed when the cancer was first diagnosed may not always show the same picture later.
For this reason, doctors may consider new molecular or biomarker testing when cancer returns or stops responding to treatment.
Second-Line and Later Treatments
If the first treatment stops controlling the cancer, another treatment may be considered. This can be called second-line treatment. If another treatment is needed later, it may be called third-line or later-line treatment.
The next option could be a different chemotherapy drug, targeted therapy, immunotherapy, hormone therapy, radiation, surgery, or a combination.
Clinical Trials
A clinical trial may also be an option for some patients, especially when standard treatments are no longer suitable or when a new treatment matches a particular cancer biomarker.
Eligibility depends on the specific study, cancer type, previous treatment, test results, general health, and other requirements.
Supportive Care Still Matters
Changing cancer treatment does not mean that symptom care should stop. Pain, nausea, tiredness, nutrition problems, breathing difficulties, and other symptoms can be treated while the oncology team works on the next cancer treatment plan.
Clinical Trials for Metastatic Cancer
Clinical trials are research studies that test new ways of preventing, diagnosing, or treating cancer. For people with metastatic cancer, a clinical trial may provide access to a treatment that is not yet part of standard care.
Researchers are studying many different approaches, including:
- New immunotherapy medicines
- New targeted drugs
- Cell-based treatments
- New drug combinations
- New radiopharmaceutical treatments
- Biomarker-guided treatments
- New ways of using existing cancer medicines
Some trials test a completely new treatment. Others test a new combination or a different way of giving an existing treatment.
Who May Qualify for a Clinical Trial?
There is no single eligibility rule. A study may require a particular cancer type, stage, biomarker, age range, previous treatment history, or level of organ function.
For example, some modern trials select patients based on a specific molecular change in the tumor, rather than only on where the cancer started.
Standard Treatment vs Investigational Treatment
Standard treatment has already been studied and is accepted for particular cancer situations. An investigational treatment is still being studied to understand how well it works and what risks it may have.
Clinical trials can offer another option, but they also have risks. A new treatment may not work, and side effects may be different from those of standard treatment.
The oncology team and trial doctors should explain the possible benefits, risks, alternatives, and study requirements before a patient decides whether to participate.
Side Effects of Metastatic Cancer Treatment
Cancer treatment can affect healthy cells and organs as well as cancer cells. The type and severity of side effects depend on the treatment being used, the dose, the treatment schedule, and the person’s health.
Some common side effects include:
Fatigue
Feeling unusually tired is common during cancer treatment. Rest can help, but severe or continuing fatigue should still be discussed with the medical team.
Nausea and Appetite Changes
Chemotherapy and some other treatments can cause nausea, changes in taste, reduced appetite, or vomiting. Medicines are available to help control nausea, and nutrition support can be useful when eating becomes difficult.
Low Blood Counts
Some treatments can reduce blood cells. This may lead to anemia, a higher risk of infection, or easier bruising and bleeding.
Neuropathy
Some cancer medicines can affect the nerves and cause tingling, numbness, burning, or weakness, especially in the hands and feet.
Hair Loss
Hair loss can happen with some chemotherapy medicines. It does not occur with every cancer treatment.
Skin Problems
Some targeted therapies and immunotherapies can cause rashes, dry skin, itching, or other skin changes.
Immune-Related Side Effects
Immunotherapy works by changing the immune response. In some patients, the immune system can become overactive and cause inflammation in organs such as the bowel, lungs, liver, thyroid, or skin.
Hormonal Side Effects
Hormone therapy can cause effects related to changes in hormone levels. The symptoms vary depending on the medicine and whether it is being used for breast cancer, prostate cancer, or another hormone-sensitive cancer.
Side effects are not the same for everyone. New or worsening symptoms should be reported to the cancer team so they can be assessed and treated early.
Palliative and Supportive Care in Metastatic Cancer
Palliative care focuses on helping a person feel better and live as comfortably as possible while dealing with cancer.
It can help with:
- Pain
- Nausea and vomiting
- Breathing problems
- Poor appetite
- Nutrition problems
- Sleep difficulties
- Fatigue
- Emotional stress
- Other symptoms caused by cancer or its treatment
Palliative care is not the same as giving up on cancer treatment. It can be provided alongside chemotherapy, immunotherapy, targeted therapy, radiation, or other cancer treatment. NCI notes that palliative care can be given at any point during cancer treatment.
Supportive care can also help family members and caregivers deal with the practical and emotional challenges that come with advanced cancer.
For many patients, controlling symptoms is an important part of the overall treatment plan, not something that has to wait until cancer treatment ends.
How Is Treatment Response Monitored?
Doctors need to know whether a treatment is helping, whether the cancer is stable, or whether it is growing despite treatment.
Several types of information may be used.
CT, MRI, and PET Scans
Imaging scans can show whether tumors have become smaller, stayed about the same size, or grown.
The type of scan depends on the cancer and the part of the body being examined.
Blood Tests
Blood tests can help doctors check organ function, blood counts, and other changes that may be important during treatment.
Tumor Markers
Some cancers produce substances that can be measured in blood or other body fluids. These are called tumor markers.
When a suitable tumor marker is available, repeated measurements may help doctors follow how the cancer is responding. But tumor markers are not useful for every cancer and are generally interpreted together with other tests.
Symptoms and Physical Examination
A scan is not the only source of information.
Doctors may also ask whether pain has improved, breathing has become easier, appetite has returned, or other symptoms have changed.
Repeat Biopsy in Selected Cases
If the cancer behaves differently or a new treatment depends on molecular information, another biopsy or liquid biopsy may sometimes be considered.
What Do Response Terms Mean?
Doctors may use terms such as:
- Complete response: No detectable signs of cancer on the tests being used.
- Partial response: The cancer has decreased in size or extent, but some disease remains.
- Stable disease: The cancer has not changed enough to be called a response or progression.
- Progressive disease: The cancer has grown or new cancer has appeared.
These terms describe what is seen on testing. They do not, by themselves, tell us exactly how long a person will live.
What Is the Life Expectancy With Metastatic Cancer?
There is no single life expectancy number for metastatic cancer.
Metastatic breast cancer, metastatic lung cancer, metastatic colon cancer, and metastatic pancreatic cancer can behave very differently. Even within the same cancer type, two patients can have different outcomes.
Doctors may consider:
- The original cancer type
- Where the cancer has spread
- How much cancer is present
- Tumor biology and biomarkers
- Previous treatments
- Response to current treatment
- Age and overall health
- Organ function
- Nutrition and physical condition
Treatment response can make a meaningful difference. Some people have metastatic cancer that remains controlled for a long time, while others have cancer that progresses more quickly. NCI notes that some people with well-controlled metastatic cancer can live for years, but the experience varies by cancer type and individual circumstances.
Survival statistics can provide information about groups of patients, but they cannot tell exactly what will happen to one person. A doctor who has reviewed the patient’s reports and treatment history is in a much better position to discuss an individual prognosis.
What Is the Cost of Metastatic Cancer Treatment?
The cost of metastatic cancer treatment can vary widely. There is no useful single price that applies to every patient.
The final cost may be affected by:
- Type of cancer
- Treatment selected
- Number of treatment cycles
- Cost of targeted or immunotherapy medicines
- Biomarker and genetic testing
- CT, MRI, PET, and other scans
- Blood tests
- Hospital admission
- Surgery
- Radiation therapy
- Supportive medicines
- Follow-up care
- Country and hospital where treatment is provided
For example, a treatment plan using an oral targeted medicine may have a very different cost from a plan involving repeated chemotherapy, surgery, radiation, or an expensive immunotherapy drug.
That is why patients should ask the treating hospital for a case-specific treatment estimate after the diagnosis and treatment plan have been reviewed.
Latest Metastatic Cancer Treatments: What Is Being Studied?
Cancer research is moving quickly, and scientists are testing ways to make treatment more precise and effective.
Some areas being studied include:
- New immunotherapy medicines
- Cell-based therapies
- New targeted drugs
- Cancer vaccines
- Bispecific antibodies
- Radiopharmaceuticals
- New drug combinations
- Biomarker-guided treatments
- New clinical trial approaches
Researchers are also studying why some tumors respond to treatment while others do not, and why cancer can become resistant after an initial response. NCI describes ongoing research into immune-based treatments, treatments aimed at specific genetic changes, and approaches that interfere with the spread of cancer cells.
What About CAR-T and Other Cell Therapies?
CAR-T cell therapy is a form of T-cell transfer therapy in which a patient’s immune cells are modified to recognize and attack cancer cells.
It has an established role in certain blood cancers, while researchers continue to study cell-based approaches in other cancers. It should not be presented as a universal treatment for metastatic solid tumors.
Similarly, cancer vaccines, bispecific antibodies, and other newer treatments are being studied in different cancer types and stages. Whether one of these options is available to a particular patient depends on the cancer type, treatment history, biomarkers, and clinical-trial eligibility.
How Fuda Cancer Hospital Can Help Metastatic Cancer Patients
For a patient with metastatic cancer, understanding the reports and available treatment options can be difficult, especially when several treatments have already been tried.
Fuda Cancer Hospital provides consultation and guidance for patients in India. Fuda’s main hospital is in Guangzhou, China, while patients in India can access consultation and guidance through its centres in Mumbai and Noida. The India team can help review medical reports and discuss treatment planning.
Medical Report and Pathology Review
Patients can share relevant medical records, including:
- Biopsy and pathology reports
- CT scans
- MRI scans
- PET-CT reports
- Previous treatment records
- Blood test results
- Other relevant medical information
Reviewing these details helps the oncology team understand the patient’s current situation before discussing possible treatment options.
Online Oncology Consultation
Patients can begin with an online consultation, which can be useful when travelling to a hospital is difficult or when they want to discuss their case before making travel arrangements.
Second Opinion
A second opinion can be useful when a patient wants another medical review of the diagnosis, scans, pathology, or proposed treatment plan.
It may also help clarify whether another treatment approach or clinical option should be discussed with the treating team.
Treatment Planning
After reviewing the available information, the oncology team can discuss possible treatment approaches based on the cancer type, extent of spread, previous treatment, and overall condition.
The final treatment decision should always be made after appropriate medical evaluation.
Treatment Coordination in Guangzhou
For patients who may need treatment at Fuda’s main facility in Guangzhou, the India team can help with the coordination process after the case has been reviewed.
Follow-Up and Supportive Care
Metastatic cancer treatment does not end with one procedure or one medicine. Follow-up may involve repeat scans, symptom management, treatment monitoring, and changes to therapy when needed.
Supportive and palliative care can also be discussed when symptom control and quality of life are important parts of the patient’s care plan.
The purpose of an oncology consultation is to understand the individual case and discuss realistic treatment options—not to promise a particular outcome.
Frequently Asked Questions About Metastatic Cancer Treatment
1. What are the latest treatments for metastatic cancer?
Current treatment options include immunotherapy, targeted therapy, chemotherapy, hormone therapy, radiation therapy, surgery in selected cases, and radiopharmaceutical treatments. Some patients may also qualify for clinical trials testing newer medicines or treatment combinations. The right option depends on the original cancer, where it has spread, previous treatment, biomarkers, and overall health.
2. Can metastatic cancer be treated?
Yes. Most types of metastatic cancer have treatment options. Treatment may aim to shrink the cancer, slow its growth, control symptoms, or keep the disease under control for as long as possible. Some people with well-controlled metastatic cancer can live for years.
3. Can metastatic cancer be cured?
In some selected situations, long-term disease control or a curative approach may be possible. However, many metastatic cancers are managed as a long-term disease rather than being completely cured. The outlook varies greatly by cancer type, tumor biology, extent of spread, and response to treatment.
4. What is the best treatment for metastatic cancer?
There is no single best treatment for every metastatic cancer. A treatment that works well for one person may not be suitable for another. Doctors consider the primary cancer, metastatic sites, biopsy results, biomarkers, previous treatment, and overall health before choosing an approach.
5. Is immunotherapy used for metastatic cancer?
Yes. Immunotherapy is used for several types of advanced and metastatic cancer. Some immunotherapies work by blocking immune checkpoints such as PD-1, PD-L1, or CTLA-4. Biomarker testing may help determine whether immunotherapy could be useful for certain patients.
6. Can targeted therapy treat metastatic cancer?
Yes, when the cancer has a molecular target that can be treated with an available medicine. Examples of targets include certain changes involving EGFR, ALK, BRAF, HER2, or other cancer-related genes and proteins. Biomarker testing can help identify these changes.
7. Can chemotherapy still work for metastatic cancer?
Yes. Chemotherapy remains an important treatment for many metastatic cancers. It may be used alone or combined with immunotherapy, targeted therapy, hormone therapy, or other treatments, depending on the cancer. Doctors can also use scans and other tests to see whether the cancer is responding.
8. What is precision medicine for metastatic cancer?
Precision medicine means using information about a person’s cancer to help select treatment. This can include testing the tumor for specific genes, proteins, or other biomarkers. Two people with the same cancer may have different molecular changes, so their treatment plans may also be different.
9. What is biomarker testing for metastatic cancer?
Biomarker testing looks for genes, proteins, or other features in cancer cells that may help guide treatment. It may identify a target for a targeted drug, provide information relevant to immunotherapy, or help identify a suitable clinical trial. Biomarker testing is often considered for advanced cancers, although it does not provide a useful treatment match in every patient.
10. Can metastatic cancer be controlled for years?
Yes, some metastatic cancers can remain controlled for years with treatment. This can mean the tumors shrink, stop growing, or remain stable for a period of time. The length of control varies widely between cancer types and individual patients.
11. What happens when metastatic cancer treatment stops working?
Doctors may repeat scans, blood tests, or other assessments to understand what has changed. In selected cases, another biopsy or biomarker test may be useful. The next step could include a different treatment, another treatment combination, a clinical trial, or local treatment such as surgery or radiation. Supportive care continues to be important as well.
12. Can metastatic cancer be treated without chemotherapy?
Yes. Depending on the cancer, treatment may include targeted therapy, immunotherapy, hormone therapy, radiation, surgery, radiopharmaceuticals, or combinations of these. Whether chemotherapy can be avoided depends on the specific cancer and the available treatment options.
13. Is surgery possible for metastatic cancer?
Sometimes. Surgery may be considered when there are a limited number of metastatic tumors, when a tumor can be safely removed, or when the primary or metastatic tumor is causing a serious problem. In selected cases, surgery may be combined with systemic treatment.
14. Can radiation help metastatic cancer?
Yes. Radiation can be used to control a specific metastatic tumor or relieve symptoms. For example, it may help with pain from bone metastases, symptoms from brain metastases, bleeding, or pressure caused by a tumor. Focused radiation may also be considered for selected patients with a limited number of metastatic tumors.
15. What are the latest treatments being studied for metastatic cancer?
Researchers are studying new immunotherapies, targeted medicines, cell therapies, bispecific antibodies, radiopharmaceuticals, cancer vaccines, biomarker-guided treatments, and new drug combinations. Clinical trials are an important way these approaches are tested before they become standard treatment.
16. What is the survival rate for metastatic cancer?
There is no single survival rate for all metastatic cancers. Survival statistics vary substantially by the original cancer type, where it has spread, tumor biology, available treatments, and other patient factors. A population-level survival statistic should not be treated as an exact prediction for one person.
17. How is metastatic cancer treatment selected?
Doctors consider the primary cancer, location and extent of spread, number and size of tumors, biopsy and pathology, biomarkers, genetic testing when appropriate, previous treatment, age, general health, organ function, symptoms, and the patient’s treatment goals. These factors help the oncology team decide which treatments are reasonable options.
18. How can Fuda Cancer Hospital help metastatic cancer patients?
Fuda Cancer Hospital can help patients with medical report review, pathology and scan review, online oncology consultation, second opinions, and treatment planning. For patients who may need treatment at its main hospital in Guangzhou, China, the India team can also assist with treatment coordination. Follow-up and supportive or palliative care can also be discussed as part of the overall care plan. Fuda Cancer Hospital
